Do It Yourself Stock Investor

Stock Analysis - Buy, Sell, Watch, etc.

Summaries of buy-side stock analysis, sell/short, and general review. The equities covered trade in the NYSE, NASDAQ and OTC. Most analysis is hosted at Seeking Alpha, DIYSI's primary editor. Some reviews are native to this site. The stock digests: Saturday Night RORC and The Swift FCF Yield are native to DIY Stock Investor.

Newest Review:

Enzymotec Is Losing The Omega-3 Krill War

by DIYSI
April 07, 2017

Enzymotec Ltd. (NASDAQ: ENZY) is of the healthcare sector with a two part portfolio of pharmaceutical and nutritional products. Products include baby formula ingredient, memory loss prescription and krill oil (a source of omega-3).

The stock reached a 52 week high of $9.32 PPS on August 2, 2016. On that day the trading volume was only 24,283. For the proceeding months the company experienced a steady sell-off, dropping to a 52 week low of $5.20 PPS on November 16, 2016. Go to Seeking Alpha for full the short-sell and pairs trade article.

Archives:

  1. 2017 Stock Reviews
  2. 2016 Stock Reviews
  3. 2015 Stock Reviews
  4. 2014 Stock Reviews
  5. Fannie Mae / GSEs

Visit DIY Stock Investor, the online newsletter-hub regarding stock analysis. Follow DIYSI's founder and 4.5-star TipRanks expert, Travis Brown.